Stand-up comedian and digital creator Aishwarya Mohanraj has candidly spoken about her 20 kg weight loss journey, revealing that she used Mounjaro, a GLP-1 medication typically prescribed for diabetes and weight management, under medical supervision.
In a recent YouTube video, the 31-year-old detailed her health challenges, the limitations of traditional weight-loss methods in her case, the side effects she experienced, and the financial burden of the treatment. Her transparency has triggered widespread discussion online around GLP-1 drugs, body image, and the stigma attached to medical weight loss.
Who Is Aishwarya Mohanraj?
Aishwarya Mohanraj is a Mumbai-based stand-up comedian and content creator known for her observational humour and relatable storytelling. She has built a strong digital presence through live performances and social media content, earning a loyal audience over the years.
Her recent disclosure about her health and weight-loss journey has further amplified conversations around PCOD, insulin resistance, and mental health.
See more of our coverage in your search results.
Add Hunterfly on GoogleWhy Did Aishwarya Mohanraj Gain Weight?
Aishwarya shared that in early 2021, she weighed approximately 51 kg. Within six months, her weight increased to nearly 70 kg.
She was later diagnosed with:
- PCOD (Polycystic Ovarian Disease)
- Hypothyroidism
Both conditions, which run in her family, can significantly impact metabolism and make weight management more challenging.
Doctors initially prescribed thyroid medication and birth control pills. However, she discontinued them due to mood-related side effects. After discovering that her PCOD was linked to insulin resistance, she was prescribed metformin.
During the same period, she was also diagnosed with clinical depression. Reflecting on that phase, she admitted feeling deeply insecure about her appearance, particularly her double chin, which led her to step away from creating online content.
See more of our coverage in your search results.
Add Hunterfly on GoogleWhy Diet And Exercise Did Not Work
At the beginning of 2025, Aishwarya decided to focus seriously on improving her health. She hired a personal trainer and nutritionist, increased protein intake, reduced junk food, and followed a consistent workout routine.
While her body measurements showed improvement, the weighing scale did not reflect significant changes.
Her progress was further disrupted when she developed plantar fasciitis, a painful inflammation of the foot, and was diagnosed with high uric acid levels. On medical advice, she had to pause intense physical activity, making sustained weight loss even more difficult.
See more of our coverage in your search results.
Add Hunterfly on GoogleHow Mounjaro Helped Her Lose 20 Kg
In May last year, Aishwarya began weekly Mounjaro injections under professional medical supervision.
She revealed that she lost around 1 kg within the first week. Over the first month, she dropped 4 kg. After six months of treatment, her weight reduced from 74 kg to 52 kg — a total loss of 20 kg.
However, she was transparent about the downsides.
She experienced:
- Severe nausea during the initial month
- Noticeable hair loss
- High treatment costs
According to her, each injection cost approximately Rs 40,000. She later reduced the dosage and has indicated that she plans to discontinue the medication.
Addressing Stigma Around Weight-Loss Drugs
Aishwarya also addressed criticism surrounding medical weight-loss treatments.
She emphasised that using prescribed medication should not be viewed as “cheating” or taking shortcuts. In her view, the idea that weight must only be lost through conventional methods ignores the medical complexities some individuals face.
At the same time, she strongly urged viewers not to self-medicate and to consult qualified healthcare professionals before considering such treatments.
Online Reaction
Her candid admission has been widely appreciated online. Many users praised her honesty about the physical, emotional, and financial aspects of the process, especially her openness about side effects and mental health struggles.
The conversation has also reignited broader debates around accessibility, body image pressures, and the growing popularity of GLP-1 medications in weight management.
